Not All Coronary Spasms Are the Same: Benefits of Acetylcholine

Patients with documented spasm to the coronary arteries present increased risk of myocardial infarction (MI) and repeat angiography, while patients with microvascular spasm are associated to recurrent angina. 

¿FFR de rutina en pacientes con síndrome coronario agudo?

Globally, the prognosis of all these patients continues to be favourable, even though acetylcholine testing might help distinguish one-another. 

Coronary spasm shows in up to 60% of patients with myocardial ischemia symptoms despite not presenting obstructive coronary lesions. 

This recent study published in JACC Interv retrospectively included consecutive patients with no obstructive coronary lesions undergoing acetylcholine testing for epicardial or microvascular spasm detection. 

Mortality, non-fatal MI, stroke, repeat angiography, recurrent symptoms, and quality of life of 736 patients were registered and followed up for 7.2 years.


Read also: IN.PACT AV ACCESS | Drug-Coated Balloons for Dialysis Fistulas.


Mortality in this followup period was 7.5%, non-fatal MI rate was 1.4%, and stroke reached 2.2%. 

Most patients reported recurrent angina (64%). This motivated repeat angiography (12%) which, same as before, showed no obstructive lesions.

Epicardial spasm was a predictor of non-fatal MI (HR: 14.4) and repeat angiography (HR: 1.7), while microvascular spasm predicted more symptoms (HR: 1.3).

Conclusion

The general prognosis of patients with coronary spasm is favourable. Acetylcholine testing helped identify patients with epicardial MI, with higher risk of non-fatal MI and repeat angiographies vs. patients with microvascular spasm associated to higher risk of recurrent angina. 

Original Title: Long-Term Follow-Up in Patients With Stable Angina and Unobstructed Coronary Arteries Undergoing Intracoronary Acetylcholine Testing.

Reference: Andreas Seitz et al. JACC Cardiovasc Interv. 2020 Aug 24;13(16):1865-1876. https://doi.org/10.1016/j.jcin.2020.05.009.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

DAPT ≤30 Days After Drug-Coated Balloon Coronary Angioplasty

Drug-coated balloon (DCB) coronary angioplasty without stent implantation has become a well-established alternative in several clinical scenarios, particularly in patients at high bleeding risk...

Is IVUS Always Necessary for Left Main Coronary Artery PCI?

Percutaneous coronary intervention (PCI) of the unprotected left main coronary artery is a highly complex procedure because of the large amount of myocardium at...

Dual-Prep Registry: Atherectomy and IVL for Severe Coronary Calcification

Severe coronary calcification remains one of the most challenging scenarios in percutaneous coronary intervention (PCI). Although rotational or orbital atherectomy and intravascular lithotripsy (IVL)...

Prehospital heparin in STEMI: A safe strategy associated with improved early reperfusion

Early reperfusion remains the main prognostic determinant in patients with ST-segment elevation myocardial infarction (STEMI). Although primary percutaneous coronary intervention (PCI) is the treatment...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Clinical and haemodynamic outcomes with contemporary intra- vs. supra-annular valves: The HERA-TAVI Registry

According to the latest European guidelines, transcatheter aortic valve implantation (TAVI) is the recommended treatment for patients aged ≥70 years with symptomatic severe aortic...

Redo-TAVI with SAPIEN 3: 30-Day Outcomes

The indications for transcatheter aortic valve implantation (TAVI) have rapidly expanded to include intermediate- and low-risk patients, extending its use to younger individuals with...

DAPT ≤30 Days After Drug-Coated Balloon Coronary Angioplasty

Drug-coated balloon (DCB) coronary angioplasty without stent implantation has become a well-established alternative in several clinical scenarios, particularly in patients at high bleeding risk...